Works matching IS 02780232 AND DT 2020 AND VI 38 AND IP 5

Results: 27
    1
    2

    Postremission therapy with repeated courses of high‐dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long‐term outcome in European leukemia net favorable and intermediate‐risk acute myeloid leukemia

    Published in:
    Hematological Oncology, 2020, v. 38, n. 5, p. 754, doi. 10.1002/hon.2806
    By:
    • Borlenghi, Erika;
    • Cattaneo, Chiara;
    • Cerqui, Elisa;
    • Archetti, Silvana;
    • Bertoli, Diego;
    • Bellotti, Daniela;
    • Gramegna, Doriana;
    • Soverini, Giulia;
    • Oberti, Margherita;
    • Schieppati, Francesca;
    • Pagani, Chiara;
    • Passi, Angela;
    • Sciumé, Margherita;
    • Farina, Mirko;
    • Carbone, Cecilia;
    • Crippa, Claudia;
    • Dalceggio, Daniela;
    • Tucci, Alessandra;
    • Rossi, Giuseppe
    Publication type:
    Article
    3

    Prognostic models integrating quantitative parameters from baseline and interim positron emission computed tomography in patients with diffuse large B‐cell lymphoma: post‐hoc analysis from the SAKK38/07 clinical trial.

    Published in:
    Hematological Oncology, 2020, v. 38, n. 5, p. 715, doi. 10.1002/hon.2805
    By:
    • Zucca, Emanuele;
    • Cascione, Luciano;
    • Ruberto, Teresa;
    • Facchinelli, Davide;
    • Schär, Sämi;
    • Hayoz, Stefanie;
    • Dirnhofer, Stefan;
    • Giovanella, Luca;
    • Bargetzi, Mario;
    • Mamot, Christoph;
    • Ceriani, Luca
    Publication type:
    Article
    4

    Clinical significance of tryptophan catabolism in follicular lymphoma.

    Published in:
    Hematological Oncology, 2020, v. 38, n. 5, p. 742, doi. 10.1002/hon.2804
    By:
    • Masaki, Ayako;
    • Ishida, Takashi;
    • Maeda, Yasuhiro;
    • Ito, Asahi;
    • Suzuki, Susumu;
    • Narita, Tomoko;
    • Kinoshita, Shiori;
    • Yoshida, Takashi;
    • Ri, Masaki;
    • Kusumoto, Shigeru;
    • Komatsu, Hirokazu;
    • Inagaki, Hiroshi;
    • Ueda, Ryuzo;
    • Choi, Ilseung;
    • Suehiro, Youko;
    • Iida, Shinsuke
    Publication type:
    Article
    5
    6

    Potential survival benefit for patients receiving autologous hematopoietic stem cell transplantation after checkpoint inhibitors for relapsed/refractory Hodgkin lymphoma: A real‐life experience.

    Published in:
    Hematological Oncology, 2020, v. 38, n. 5, p. 737, doi. 10.1002/hon.2803
    By:
    • Casadei, Beatrice;
    • Argnani, Lisa;
    • Morigi, Alice;
    • Lolli, Ginevra;
    • Broccoli, Alessandro;
    • Pellegrini, Cinzia;
    • Nanni, Laura;
    • Stefoni, Vittorio;
    • Coppola, Paolo Elia;
    • Carella, Matteo;
    • Cavo, Michele;
    • Zinzani, Pier Luigi
    Publication type:
    Article
    7
    8
    9

    MicroRNA profiling of blastic plasmacytoid dendritic cell neoplasm and myeloid sarcoma.

    Published in:
    2020
    By:
    • Sapienza, Maria Rosaria;
    • Fuligni, Fabio;
    • Melle, Federica;
    • Tabanelli, Valentina;
    • Indio, Valentina;
    • Laginestra, Maria Antonella;
    • Motta, Giovanna;
    • Mazzara, Saveria;
    • Cerroni, Lorenzo;
    • Pileri, Alessandro;
    • Facchetti, Fabio;
    • Paulli, Marco;
    • Cascione, Luciano;
    • Laganà, Alessandro;
    • Berti, Emilio;
    • Ferracin, Manuela;
    • Agostinelli, Claudio;
    • Sabattini, Elena;
    • Croce, Carlo Maria;
    • Pileri, Stefano Aldo
    Publication type:
    Letter
    10
    11
    12
    13
    14

    Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma.

    Published in:
    Hematological Oncology, 2020, v. 38, n. 5, p. 698, doi. 10.1002/hon.2792
    By:
    • Della Starza, Irene;
    • De Novi, Lucia Anna;
    • Cavalli, Marzia;
    • Novelli, Noemi;
    • Soscia, Roberta;
    • Genuardi, Elisa;
    • Mantoan, Barbara;
    • Drandi, Daniela;
    • Ferrante, Martina;
    • Monitillo, Luigia;
    • Barbero, Daniela;
    • Ciabatti, Elena;
    • Grassi, Susanna;
    • Bomben, Riccardo;
    • Degan, Massimo;
    • Gattei, Valter;
    • Galimberti, Sara;
    • Di Rocco, Alice;
    • Martelli, Maurizio;
    • Cortelazzo, Sergio
    Publication type:
    Article
    15
    16

    Association of Epstein–Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency‐associated lymphoproliferative disorders in patients with autoimmune diseases.

    Published in:
    Hematological Oncology, 2020, v. 38, n. 5, p. 799, doi. 10.1002/hon.2790
    By:
    • Fujimoto, Katsuya;
    • Hatanaka, Kanako C.;
    • Hatanaka, Yutaka;
    • Kasahara, Ikumi;
    • Yamamoto, Satoshi;
    • Tsuji, Takahiro;
    • Nakata, Masanobu;
    • Takakuwa, Yasunari;
    • Haseyama, Yoshihito;
    • Oyamada, Yumiko;
    • Yonezumi, Masakatsu;
    • Suzuki, Hiroaki;
    • Sakai, Hajime;
    • Noguchi, Hiroko;
    • Mori, Akio;
    • Nishihara, Hiroshi;
    • Teshima, Takanori;
    • Matsuno, Yoshihiro
    Publication type:
    Article
    17

    Targeted‐dose of busulfan: Higher risk of sinusoidal obstructive syndrome observed with systemic exposure dose above 5000 µMol⸱min. A historically controlled clinical trial.

    Published in:
    Hematological Oncology, 2020, v. 38, n. 5, p. 773, doi. 10.1002/hon.2789
    By:
    • Esteves, Iracema;
    • Santos, Fabio Pires Souza;
    • Ribeiro, Andreza Alice Feitosa;
    • Seber, Adriana;
    • Sugawara, Eduardo Kinio;
    • Sobrinho, Jairo José do Nascimento;
    • Barros, José Carlos;
    • Oliveira, José Salvador Rodrigues;
    • Fernandes, Juliana Folloni;
    • Hamerschlak, Nelson;
    • Andersson, Borje S.;
    • de Lima, Marcos;
    • Kerbauy, Fabio Rodrigues
    Publication type:
    Article
    18
    19

    A phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha‐2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia (CML) not achieving a deep molecular response (molecular remission 4.5)—AGMT_CML 1

    Published in:
    Hematological Oncology, 2020, v. 38, n. 5, p. 792, doi. 10.1002/hon.2786
    By:
    • Heibl, Sonja;
    • Buxhofer‐Ausch, Veronika;
    • Schmidt, Stefan;
    • Webersinke, Gerald;
    • Lion, Thomas;
    • Piringer, Gudrun;
    • Kuehr, Thomas;
    • Wolf, Dominik;
    • Melchardt, Thomas;
    • Greil, Richard;
    • Thaler, Josef
    Publication type:
    Article
    20
    21

    Targeted next‐generation sequencing reveals molecular heterogeneity in non‐chronic lymphocytic leukemia clonal B‐cell lymphocytosis.

    Published in:
    Hematological Oncology, 2020, v. 38, n. 5, p. 689, doi. 10.1002/hon.2784
    By:
    • Defrancesco, Irene;
    • Zibellini, Silvia;
    • Boveri, Emanuela;
    • Frigeni, Marco;
    • Ferretti, Virginia Valeria;
    • Rizzo, Ettore;
    • Bonometti, Arturo;
    • Capuano, Francesca;
    • Candido, Chiara;
    • Rattotti, Sara;
    • Tenore, Annamaria;
    • Picone, Cristina;
    • Flospergher, Elena;
    • Zerbi, Caterina;
    • Bergamini, Fabio;
    • Fabbri, Nicole;
    • Cristinelli, Caterina;
    • Varettoni, Marzia;
    • Paulli, Marco;
    • Arcaini, Luca
    Publication type:
    Article
    22
    23
    24
    25
    26
    27

    Issue Information.

    Published in:
    Hematological Oncology, 2020, v. 38, n. 5, p. 1, doi. 10.1002/hon.2644
    Publication type:
    Article